A Retrospective Study to Characterize Participants With Propionic Acidemia

PreclinicalRecruiting

0 views this week 0 watching

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Propionic Acidemia

Conditions

Propionic Acidemia

Trial Timeline

Jun 16, 2023 → Sep 30, 2026

NCT ID

NCT05769621

About A Retrospective Study to Characterize Participants With Propionic Acidemia

A Retrospective Study to Characterize Participants With Propionic Acidemia is a preclinical stage product being developed by Moderna for Propionic Acidemia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05769621. Target conditions include Propionic Acidemia.

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05769621	Preclinical	Recruiting	Jun 16, 2023	Sep 30, 2026	Propionic Acidemia

Competing Products

3 competing products in Propionic Acidemia

See all competitors

Product	Company	Stage
"The MaP Study": Mapping the Patient Journey in MMA and PA	Moderna	Preclinical
mRNA-3927	Moderna	Phase 2
mRNA-3927	Moderna	Phase 2